M11.269 Other chondrocalcinosis, unspecified knee

Name of the Condition

• Other chondrocalcinosis, unspecified knee

Summary

Other chondrocalcinosis, unspecified knee refers to the deposition of calcium-containing crystals in the knee joint tissues, excluding calcium pyrophosphate dihydrate (CPPD) or hydroxyapatite. This condition causes joint inflammation, pain, and potential structural damage, often mimicking other arthritic diseases. Diagnosis typically requires identifying the specific crystal type through joint fluid analysis or tissue sampling.

Causes

Other chondrocalcinosis, unspecified knee is caused by the deposition of non-CPPD, non-hydroxyapatite calcium crystals (e.g., calcium oxalate, calcium phosphate) in the knee’s cartilage, synovium, or surrounding tissues. The exact triggers vary but may include metabolic imbalances, genetic factors, or underlying systemic conditions. Crystal formation provokes an inflammatory response, leading to joint symptoms.

Risk Factors

• Metabolic disorders (e.g., hyperoxaluria, hypophosphatasia).
• Chronic kidney disease or dialysis.
• Genetic predisposition to crystal formation.
• Exposure to certain medications or toxins.
• Knee trauma or surgery.

Symptoms

• Knee pain, swelling, and stiffness.
• Warmth and redness over the affected joint.
• Reduced range of motion.
• Recurrent episodes of inflammation.
• Systemic symptoms (e.g., fever) in severe cases.

Diagnosis

Diagnosis involves clinical evaluation, imaging (e.g., X-ray, ultrasound), and laboratory testing to identify crystal type. Joint fluid analysis or tissue sampling is often required to confirm the presence of non-CPPD, non-hydroxyapatite crystals and rule out other conditions.

Treatment Options

Treatment focuses on reducing inflammation and managing pain, including nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, or colchicine. Underlying metabolic or systemic causes may require targeted therapy. Physical therapy and activity modification can help preserve joint function.

Prognosis and Follow-Up

Prognosis depends on the underlying cause and severity of crystal deposition. Early diagnosis and treatment may prevent progressive joint damage. Regular follow-up with imaging and clinical assessments is recommended to monitor for complications.

Complications

Potential complications include chronic joint pain, reduced mobility, cartilage damage, and secondary osteoarthritis. Severe cases may lead to joint deformity or functional impairment.

Lifestyle & Prevention

Maintaining a healthy weight, avoiding joint overuse, and managing underlying metabolic conditions can reduce risk. Regular exercise and joint-friendly activities may help preserve function.

When to Seek Professional Help

Seek care if knee pain, swelling, or stiffness persists, worsens, or interferes with daily activities. Prompt evaluation is important if systemic symptoms (e.g., fever) or sudden joint redness occur.

Tips for Medical Coders

Use M11.269 for unspecified knee involvement. Document the absence of CPPD or hydroxyapatite crystals and specify the knee as the affected site. Include clinical details supporting crystal type and joint involvement for accurate coding.